Tenpoint Therapeutics is seeking to expand availability of its once-daily presbyopia eye drop beyond the United States, announcing a submission to apply for regulatory

United States-based clinical-stage biotechnology company TearSolutions is dosing its first patients in a clinical trial of Lacripep, a potential first-in-class treatment for neurotrophic keratitis.

Canadian researchers have developed a digital manufacturing platform that could one day allow patient-specific contact lenses to be 3D-printed in under 20 minutes.

Two-year data from the Phase IIIb/IV SALWEEN study of Vabysmo (faricimab, Roche), presented at the 19th Asia-Pacific Vitreo-retina Society (APVRS) Congress in Australia, showed